Fujifilm to restart clinical trial of Avigan for COVID-19 treatment: Report Ruchika Sharma22 Feb 2021 12:30 PM ISTTokyo: Fujifilm Holdings Corp will restart a clinical trial in Japan of its antiviral drug Avigan for the treatment of COVID-19, the Nikkei newspaper...
Dr Reddys, GRA terminate Avigan Trial Study for COVID-19 in Kuwait Ruchika Sharma28 Jan 2021 12:00 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) have recently announced the termination of Avigan Trial Study conducted...
Dr Reddys unveils COVID drug Favipiravir under brand name AVIGAN in India, offers free home delivery service Ruchika Sharma20 Aug 2020 12:04 PM ISTHyderabad: Hyderabad-based drugmaker, Dr Reddy's Laboratories Ltd. has recently joined the Favipiravir race, as it launched the Covid-19 drug under...
COVID 19: Dr Reddy's Labs collaborates with FUJIFILM, Global Response Aid for Avigan (favipiravir) Ruchika Sharma2 July 2020 12:48 PM ISTFUJIFILM will grant Dr.Reddy's right to use Avigan®'s patents of formulation and manufacturing method.
COVID-19: Strides Pharma gets DCGI nod to conduct favipiravir trials in India Ruchika Sharma22 May 2020 12:00 PM ISTFavipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in...
Hikal develops generic API of Avigan Ruchika Sharma17 May 2020 12:00 PM ISTFavipiravir is a generic version of Avigan of Fujifilm Toyama Chemical Co. Ltd., Japan, a subsidiary of Fujifilm Corporation
Covid-19 Treatment: Russia sees promising results in early trials of Favipiravir Ruchika Sharma17 May 2020 10:30 AM ISTMoscow: A candidate drug for treating the new coronavirus, Favipiravir, has produced promising results in early clinical trials in Russia, according...
Glenmark begins Phase 3 Clinical Trials on Antiviral Favipiravir for coronavirus in India Ruchika Sharma12 May 2020 12:57 PM ISTFavipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections
COVID-19 Battle: Strides Pharma develops, commercializes global sale of Antiviral Favipiravir Ruchika Sharma30 April 2020 11:30 AM ISTFavipiravir is an antiviral medication that was initially developed to treat influenza in Japan
